Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carbetocin vs Oxytocin in Elective Caesarean Section With High Risk of Postpartum Hemorrhage
NCT02391636Phase 4Completed
- Sponsor
- Ghamra Military Hospital
- Start
- Feb 2015
- Primary completion
- Sep 2016
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of carbetocin in postpartum hemorrhage (PPH) (2 arms), sponsored by Ghamra Military Hospital. Primary endpoint: Amount of blood loss at 24 hours. Started Feb 2015; status: completed.
02
Drugs
carbetocin
03
Conditions
postpartum hemorrhage (PPH)
Beyond the preview
Go deeper on NCT02391636.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02391636.